The global biophotonics market is expected to record a CAGR of 11.3% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 54,320.0 million. By 2033, the valuation is anticipated to reach US$ 1,58,457.0 million. The biophotonics market is expected to grow significantly in the coming years, driven by increasing demand for non-invasive and non-destructive diagnostic tools and advancements in photonics and related technologies.
Biophotonics Market is Expected to Expand Significantly in the Coming Years Due to Several Growth Factors, Including
Advances in photonics and related technologies, such as imaging and sensing, have enabled the development of advanced biophotonics technologies that offer high-resolution and high-speed imaging capabilities, as well as improved sensitivity and specificity in disease diagnosis.
The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes drives the demand for biophotonics-based diagnostic and therapeutic technologies.
Growing investments in research and development activities in biophotonics and related technologies are driving the development of new and advanced biophotonics technologies.
Governments worldwide are supporting the development of biophotonics technologies through funding and regulatory initiatives, which are expected to drive the market's growth.
The ageing population is increasing the demand for healthcare services, including diagnostic and therapeutic procedures, fueling the demand for biophotonics-based technologies.
The growing trend towards personalized medicine drives the demand for biophotonics-based technologies, as they offer high-resolution imaging and molecular analysis capabilities for personalized disease diagnosis and treatment.
| Attributes | Value |
|---|---|
| Biophotonics Value (2022) | US$ 52,538.9 million |
| Biophotonics Market Expected Value (2023) | US$ 54,320.0 million |
| Biophotonics Market Forecast Value (2033) | US$ 1,58,457.0 million |
| Biophotonics Market Expected CAGR (2023 to 2033) | 11.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Addressing these challenges is likely important to ensure the growth and development of the biophotonics market in the coming years. This may require investments in research and development, standardization efforts, regulatory reforms, and education and training programs to increase healthcare professionals' awareness and expertise in biophotonics.
Principal Consultant
Biophotonics technology is applicable across multiple industry sectors, including biotechnology, diagnostics, therapeutics, and agriculture. Optical techniques allow for the non-invasive observation of biological cells while maintaining their integrity.
This involves interactions such as absorption, detection, emission, reflection, radiation, modification, and creation between biological cells or molecules and light. Biophotonics has the potential to revolutionize the way we understand and approach healthcare, offering new avenues for disease detection and treatment.
Biophotonics technology is poised to significantly impact a wide range of fields, including environmental monitoring, food analysis, Raman spectroscopy, endoscopy, dosimetry, and dentistry.
Biophotonics enables the non-invasive observation and analysis of biological cells and tissues, offering new insights and opportunities for disease diagnosis and treatment.
The biophotonics market report provides an overview of this rapidly developing field, highlighting its potential for improving healthcare outcomes through light-based technologies. Biophotonics has the potential to revolutionize various sectors and enable us to cure diseases in more effective ways.
Biophotonics is categorically split into three components: biophotonics end user, biophotonics technology, biophotonics applications, and biophotonics region-wise analysis.
The biophotonics market report includes a detailed analysis of each vertical and sub-vertical, providing insights into the market size and growth potential. The report also segments end-use sectors into medical diagnostics, medical therapeutics, test components, and non-medical end users. The application segment is also divided into see-through imaging, spectro-molecular, light therapy, biosensors, microscopy, and surface imaging. By breaking down the market into these segments, the report offers a comprehensive understanding of the various applications of biophotonics technology and its potential impact across multiple sectors.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The biophotonics market report also provides a comprehensive regional analysis of the industry. The report evaluates the market size and growth potential of biophotonics technology across key regions including North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East and Africa (MEA)
In North America, the biophotonics market is expected to witness significant growth due to the presence of key players in the region and the increasing demand for advanced diagnostic and therapeutic solutions.
In Asia Pacific, the biophotonics market is expected to experience substantial growth due to rising investments in healthcare infrastructure, increasing healthcare expenditure, and a huge patient pool. China is expected to record a CAGR of 12.4% over the forecast period.
The biophotonics market in Europe is a significant player in the global biophotonics industry, driven by the growing ageing population, increasing healthcare expenditure, and demand for improved healthcare services. The region has a well-established healthcare infrastructure and a significant presence of key players in the biophotonics market.
According to the FMI analysis, the medical diagnostics sector is expected to account for a significant share of the biophotonics market in Europe, driven by increasing demand for non-invasive and advanced diagnostic solutions. The microscopy application segment is also expected to witness substantial growth in the region, driven by the increasing use of microscopy techniques in medical research and diagnosis.
In general, the biophotonics market is expected to experience strong growth across all regions, driven by increasing demand for non-invasive and advanced diagnostic and therapeutic solutions, as well as technological advancements in the field of photonics.
Leading companies like Becton Dickinson & Co., Affymetrix Inc., Olympus America, Andor Technology, Hamamatsu Technologies, and Carl Zeiss are employing various strategies to stay ahead in the market. These tactics include partnering with other companies, signing sales contracts, forming strategic alliances, diversifying their offerings, launching innovative products, engaging in mergers and acquisitions, conducting research and development, upgrading their technologies, expanding their product lines, hiring technical experts, forming joint ventures, collaborating with other businesses, and obtaining product approvals. By adopting these measures, these companies aim to gain a competitive edge over their rivals.
Developments in the Market
With this advanced technology, physicians can perform minimally invasive procedures to biopsy mediastinal and hilar lymph nodes with greater precision, enhancing their ability to diagnose and stage lung cancer more effectively.
On April 30, 2021, Olympus launched a new line of premium endoscopes specifically designed for advanced diagnostic and therapeutic procedures. The H-SteriScope portfolio is the result of a collaborative effort between Olympus, Veran Medical Technologies, Inc., and Hunan Vathin Medical Instrument Co., Ltd.
This collaboration has enabled Olympus to expand its offerings and deliver advanced medical technology to its customers. The H-SteriScope portfolio is a significant addition to the company's product line and reflects its commitment to developing innovative solutions that improve patient outcomes.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Growth Rate (2023 to 2033) | 11.3% CAGR |
| Market Analysis | US$ million for Market Value |
| Market Value for 2022 | US$ 52,538.9 million |
| Key Regions Covered | North America, Latin America, Europe, South Asia and Pacific, East Asia, Middle East & Africa |
| Key Segments Covered | Product Type, Material Type, Pressure Intake, Application, and Region |
| Key Companies Profiled | Becton Dickinson & Co., Affymetrix Inc., Olympus America, Andor Technology, Hamamatsu Technologies, and Carl Zeiss |
| Report Coverage | Market Forecast, Competitive Landscape, Region-wise and Category-wise Insights, Key Trends, Key Challenges |
| Customization & Pricing | Available upon Request |
The CAGR for the market is 11.3% until 2033.
From 2018 to 2022, the market expanded at a 3.4% CAGR.
China is expected to record a 12.4% CAGR until 2033.
Olympus America, Andor Technology, and Becton Dickinson & Co. are key players.
Chronic diseases and advanced treatments are expected to drive the market.
1. Executive Summary | Biophotonics Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
5.3.1. See-Through Imaging
5.3.2. Microscopy
5.3.3. Spectro Molecular
5.3.4. Inside Imaging
5.3.5. Analytics Sensing
5.3.6. Light Therapy
5.3.7. Surface Imaging
5.3.8. Biosensors
5.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Tests and Components
6.3.2. Medical Therapeutics
6.3.3. Medical Diagnostics
6.3.4. Non-Medical Application
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Application
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Application
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Application
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Application
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By End User
10.4. Key Takeaways
11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Singapore
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Application
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By End User
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Application
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By End User
12.4. Key Takeaways
13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Application
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.3.3. By End User
13.4. Key Takeaways
14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Application
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Application
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Application
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Application
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Application
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Application
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Application
15.5.2.2. By End User
15.6. United kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Application
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Application
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Application
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Application
15.9.2.2. By End User
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Application
15.10.2.2. By End User
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Application
15.11.2.2. By End User
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Application
15.12.2.2. By End User
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Application
15.13.2.2. By End User
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Application
15.14.2.2. By End User
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Application
15.15.2.2. By End User
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Application
15.16.2.2. By End User
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Application
15.17.2.2. By End User
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Application
15.18.2.2. By End User
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Application
15.19.2.2. By End User
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Application
15.20.2.2. By End User
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Application
15.21.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Application
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Becton, Dickinson & Co.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Affymetrix Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Carl Zeiss
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Olympus America
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Andor Technology
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Hamamatsu Photonics
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Thermofisher Scientific
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. PerkinElmer
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Zenalux Biomedical Inc.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. NU Skin Enterprises
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Chemicals & Materials Insights
View Reports
Biophotonics Market
